DNA PROBES FOR DIAGNOSIS OF GONOCOCCAL DISEASE
DNA PROBES FOR DIAGNOSIS OF GONOCOCCAL DISEASE
批准号:
3488885
负责人:
RALPH L MCDADE
金额:
$4.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-08-01 至 1989-01-31
关键词:
Neisseria gonorrhoeae Neisseriaceae bacterial DNA biotin communicable disease diagnosis diagnosis design /evaluation diagnosis quality /standard enzyme complex genetic strain genome gonorrhea nucleic acid chemical synthesis nucleic acid hybridization nucleic acid probes nucleic acid sequence oligonucleotides rapid diagnosis sexually transmitted diseases spectrometry
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Development of an efficacious and cost-effective diagnostic test
for Neisseria gonorrhoeae infection is the goal of this project.
Although current diagnostic methods are sensitive and specific,
they are time consuming and costly. Because of the enormous
morbidity of gonococcal infection in the U.S., the potential for
commercial application of such a test is excellent. This phase I
proposal examines the feasibility of two DNA "probes" as
diagnostic reagents. One will be based on the DNA sequence of a
26 base-pair repetitive element found in the genomes of Neisseria
spp. A 21 base oligonucleotide will be commercially synthesized
and enzymatically biotinylated. The second probe will be a single
stranded DNA fragment of the gonococcal outer membrane
protein III gene. This probe will be biotinylated chemically. A
restriction fragment of this gene demonstrating the best species
specificity will be determined by hybridization analysis with
genomic DNA from several Neisseria spp. Both probes will be
examined for sensitivity using purified gonococcal DNA and
hybridization analysis on nitrocellulose. Biotinylated DNA probes
will be detected with complexes of streptavidin and biotinylated
alkaline phosphatase or urease. Probes will be considered for
further development (Phase II), if their level of sensitivity allows
detection of less than ten thousand gonococci with insignificant
background "noise".
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金